981/1507US=84 / Biol/Mol
Cordeiro MF, Maass A, Migdal C, Guo L. TGF-B in inflammation and fibrosis: TGF-B-related antifibrotic strategies in the eye. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 663-73. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3.

TGF-B; SIRNA; OCULAR CICATRIZES; GLAUCOMA; ANTIFIBROTICO; OLIGONUCLEOTIDOS ANTI-SENTIDO; ANTICORPOS NEUTRALIZANTES; ANTAGONISTA


982/1507US=84 / Biol/Mol
Cha J, Falanga V. TGF-B in inflammation and fibrosis: transforming growth factor-B in cutaneous tissue repair. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 675-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3.

FACTOR DE CRESCIMENTO TRANSFORMANTE-B; REPARACAO DE FERIDAS; REPARACAO TECIDUAL; MATRIZ; FIBROBLASTOS; QUERATINOCITOS


983/1507US=84 / Biol/Mol
Dotor J, Pablos JL. TGF-B in inflammation and fibrosis: topical application of TGF-B1 peptide inhibitors for the therapy of skin fibrosis. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 693-702. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3.

FACTOR DE CRESCIMENTO TRANSFORMANTE-B; REPARACAO DE FERIDAS; REPARACAO TECIDUAL; MATRIZ; FIBROBLASTOS; QUERATINOCITOS


984/1507US=84 / Biol/Mol
Liu W, Chua C, Gao Z, Wu X, Cao Y. TGF-B in inflammation and fibrosis: overexpressed truncated TGF-B type II receptor inhibits fibrotic behavior of keloid fibroblasts in vitro and experimental scar formation in vivo. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 703-21. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3.

TRUNCATED TGF-B RECEPTOR II; TGF-B SINALIZACAO; FERIR CICATRIZES; QUELOIDE; TERAPIA GENETICA CICATRIZ


985/1507US=84-A / Biol/Mol
Rane SG, Lin HM, Lee JH. Transformig growth factor-B in developing and advanced cancers: transforming growth factor-B signaling in pancreas development and pancreatic disease. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 3-19. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; SMAD4 (DPC4); PANCREAS; CANCER DE PANCREAS; METASTASE


986/1507US=84-A / Biol/Mol
Weber SM, Lu SL, Bernstein S, Wang XJ. Transformig growth factor-B in developing and advanced cancers: role of transforming growth factor-B in the pathogenesis of human head and neck squamous cell carcinoma. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 21-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FACTOR DE CRESCIMENTO TRANSFORMANTE-B; CARCINOMA DE CELULAS ESCAMOSAS. CABECA E PESCOCO; TRANSGENICA RATO; RATO KNOCKOUT


987/1507US=84-A / Biol/Mol
Karunagaran D, Jinesh G. Transformig growth factor-B in developing and advanced cancers: TGF-B, smads and cervical cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 33-49. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; SMADS; CANCER CERVICAL; HPV; VIRUS DO PAPILOMA HUMANO; HELA; SIHA


988/1507US=84-A / Biol/Mol
Ungefroren H. Transformig growth factor-B in developing and advanced cancers: TGF-B signaling and biglycan in pancreatic cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 51-62. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

CANCER DE PANCREAS; RECEPTOR; SMAD; BIGLICAM; PARAGEM DO CRESCIMENTO; DANO DO DNA-45B; P38 CINASE DE PROTEINA ACTIVADA POR MITOGENIO; NADPH OXIDASE; PROTEINA QUINASE C; FACTOR DE CRESCIMENTO TRANSFORMANTE-B


989/1507US=84-A / Biol/Mol
Piestrzeniewicz-Ulanska D, McGuinness DH, Yeaman GR. Transformig growth factor-B in developing and advanced cancers: TGF-B signaling in endometrial cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 63-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

CANCER ENDOMETRIAL; ENDOMETRIO; SMADS; HORMONIOS ESTEROIDES; TGF-B; TGF-B RECEPTORES


990/1507US=84-A / Biol/Mol
Wang GY, Hu XH, Zhang RM, Leach L, Luo ZW. Transformig growth factor-B in developing and advanced cancers: TGF-B ligands, TGF-B receptors, and lung cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 79-93. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

DNA METILACAO; CANCER DE PULMAO; TERAPIA DO CANCER; SMAD PROTEINAS; MUTACAO GENETICA; MIGRACAO DO TUMOR; TGF-B LIGANDOS; TGF-B RECEPTORES


991/1507US=84-A / Biol/Mol
Bartholin L, Guise T. Transformig growth factor-B in developing and advanced cancers: role of TGF-B in osteolytic bone metastases. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 95-123. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; MAMA; OSSO; METATASE; SMAD; TERAPIA


992/1507US=84-A / Biol/Mol
Buck M, Knabbe. Transformig growth factor-B in developing and advanced cancers: hormonal regulation of transforming growth factor-B in breast cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 125-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

ANTIESTROGENIO; CANCER DE MAMA; ESTROGENIO; REGULACAO HORMONAL; PROGESTINA; RETINOIDE; RESISTENCIA; TGF-B


993/1507US=84-A / Biol/Mol
Fukuchi M, Kato H, Kuwano H. Transformig growth factor-B in developing and advanced cancers: TGF-B and progression of esophageal cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 133-40. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; SMAD; PROGNOSTICO; CANCER DE ESOFAGO; DEGRADACAO


994/1507US=84-A / Biol/Mol
Todorovic-Rakovic N. Transformig growth factor-B in developing and advanced cancers: TGF-B and HER2/ErbB2 and beast cancer progression. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 141-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; HER2; CANCER DE MAMA; SMAD; RAS/MAPK; SINERGISMO; PROGRESSAO


995/1507US=84-A / Biol/Mol
Becker C, Neurath MF. Transformig growth factor-B in developing and advanced cancers: TGF-B dependent T-Cell regulation in colitis and colon cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 153-66. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; CD25; COLITE; CANCRO DO COLON; TREG; FOXP3; CELULA T; REGULACAO


996/1507US=84-A / Biol/Mol
Gagliardini E, Benigni A. Transformig growth factor-B in developing and advanced cancers: role of transforming growth factor-B in the kidney-physiology and pathology. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 167-79. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FATOR TRANSFORMADOR DE CRESCIMENTO - B; PODOCITOS; FIBROSE RENAL; NEFROPATIA PROGRESSIVA; PROTEINURIA; GLOMERULOESCLEROSE


997/1507US=84-A / Biol/Mol
Wolfrain LA, Letterio JJ. Transformig growth factor-B in developing and advanced cancers: perturbations of TGF-B signaling in leukocytes as drivers of leukemogenesis and epithelial tumorigenesis. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 181-202. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FATOR TRANSFORMADOR DE CRESCIMENTO - B; TGF-B; SMAD; LEUCEMOGENESE; CELULAS T; IMUNOTERAPIA TUMOR; MODELOS DE RATO; ESTROMA; LINFOCITOS EPITELIAIS INTERACCOES


998/1507US=84-A / Biol/Mol
Vivien D, Benchenane K, Ali C. Transformig growth factor-B in developing and advanced cancers: transforming growth factor-B in brain functions and dysfunctions. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 203-18. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; DOENCA DE ALZHEIMER'S; INFLAMACAO; CEREBRO; GOLPE


999/1507US=84-A / Biol/Mol
Yasui H, Hideshima T, Anderson KC. Transformig growth factor-B in developing and advanced cancers: inhibition of TGF-B signaling in multiple myeloma and its bone marrow microenvironment. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 219-27. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; IL-6; VEGF; TGF-B RECEPTOR TIPO I; TBRI; MIELOMA MULTIPLO; MICROAMBIENTE DA MEDULA OSSEA; FATOR TRANSFORMADOR DE CRESCIMENTO; FACTOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INIBIDOR DE QUINASE SD-208


1000/1507US=84-A / Biol/Mol
Song K, Danielpour D. Transformig growth factor-B in developing and advanced cancers: key roles of TGF-B and smad3 in prostate cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 229-46. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

PROSTATA; SMAD3; IGF-I; AKT; MTOR; ARA55/HIC-5; RECEPTOR DE ANDROGENO


Primeira | Anterior | Próxima | Última